Illumina Inc. v. BGI Genomics Co., Ltd.

Good Law
United States District Court, Northern District of CaliforniaNovember 24, 20203:20-cv-01465California9,068 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 ILLUMINA INC., et al., Case No. 20-cv-01465-WHO

Plaintiffs,

CLAIM CONSTRUCTION

v.

BGI GENOMICS CO., LTD., et al., Defendants.

12 INTRODUCTION In this matter, plaintiffs Illumina Inc. and Illumina Cambridge Ltd. (collectively, “Illumina”) assert infringement claims against defendants BGI Genomics Co., Ltd., BGI Americas Corp., MGI Tech Co., Ltd., MGI Americas, Inc., and Complete Genomics Inc. (collectively “BGI”). The parties request construction of five terms from three patents asserted by Illumina, all of which relate to sequencing of nucleic acids. My constructions are below. BACKGROUND I. PROCEDURAL BACKGROUND BGI and Illumina are competitors in the field of genomic sequencing. This matter, (“Illumina II”) is related to Illumina Inc., et al., v. BGI Genomics Co., Ltd., et al., Case No. 19-cv- 3770 (N.D. Cal.) (“Illumina I”). Illumina filed the complaint in Illumina I on June 27, 2019. Illumina…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.